What are the challenges and opportunities to the industry?
The global generic drugs industry has seen unprecedented growth in recent years, driven by a number of lead therapies losing patent protection and by favourable operating markets where containment of drugs expenditure has been central to controlling health costs.
At the same time, a number of companies have consolidated their market position, with over 10 leading generic companies being swallowed up or merged in the last 2-3 years. With the domination of a number of key players such as Sandoz and Teva, consolidation of the industry looks set to continue.
The immediate future for generics looks good: patent expiries on leading brands will continue – but what then? The number of NCEs which have been coming to market over recent years has not been great, and with no new products then the generic opportunities will decrease. Furthermore, the trend to biopharmaceuticals and the rise of target specific therapies will require the industry to rethink its “stack it high sell it cheap” model of working in a world where biosimilars will be its business.
How are Generic Drugs Business products researched?
All of Espicom’s generic business publications are written by a dedicated full-time team of researchers and editors who collectively provide many years experience of market and company analysis. Espicom only uses primary source material and is in continuous contact with companies, regulatory authorities, statistics offices and trade bodies. The market forecasts, where provided, are robust and statistically verified, taking into account a number of key market drivers and dampeners. Direct industry access allied to thoughtful analysis of developments means our reputation for comprehensive and insightful coverage has been well earned.
How frequently is the information updated?
That depends on the service. World Generic Markets is published every two weeks, while Biosimilars Business Review is published quarterly. Online news services are updated daily. Management reports are produced in response to events and interest, while popular reference reports such as The World Generic Market Report are published annually.
What formats are available?
Most of our reports and news publications are available in print, pdf or web. Some products like generics news and tracker services are, by their nature, available over the web only.
Can I buy discounted packages?
You can buy any combination of reports and information services that are of interest to you very cost-effectively. By using our unique web interface for access, you can build a very specific library of information which, with a distribution licence, can be sharedwith colleagues near and far.
For a no-commitment discussion or to arrange an online demonstration, please contact Clare Mills by email clare_mills@genericdrugsbusiness.com or telephone +44 (0) 1243 756051 or through our contact form.
|
